Trial Outcomes & Findings for Community Support Program for Lung Cancer Screening (NCT NCT06207435)
NCT ID: NCT06207435
Last Updated: 2025-09-02
Results Overview
The Primary Outcome measures the rate of appointment attendance across three groups: West Philadelphia CSP Participants (eligible West Philadelphia residents who opted into the CSP), West Philadelphia Non CSP Participants (eligible West Philadelphia residents who did not opt into the CSP), and Southwest Philadelphia Residents (patients who did not receive an option to participate in the CSP).
COMPLETED
NA
242 participants
12 months
2025-09-02
Participant Flow
Participant milestones
| Measure |
West Philadelphia CSP Participants
For eligible residents of West Philadelphia, patients are contacted by Community Support Program Representative and offered free Lyft transportation to and from appointment. If patient has other questions about their upcoming appointment (location, time, etc.), Patient Navigator assists in answering questions. This group opted into the CSP.
|
West Philadelphia Non CSP Participants
For eligible residents of West Philadelphia, patients are contacted by Community Support Program Representative and offered free Lyft transportation to and from appointment. If patient has other questions about their upcoming appointment (location, time, etc.), Patient Navigator assists in answering questions. This group did not opt into the CSP.
|
Southwest Philadelphia Residents
For patients outside West Philadelphia, no contact is made and no free transportation is provided. Research coordinator logs their appointment attendance after the appointment date in question.
|
|---|---|---|---|
|
Overall Study
STARTED
|
26
|
165
|
51
|
|
Overall Study
COMPLETED
|
26
|
165
|
51
|
|
Overall Study
NOT COMPLETED
|
0
|
0
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Community Support Program for Lung Cancer Screening
Baseline characteristics by cohort
| Measure |
West Philadelphia CSP Participants
n=26 Participants
For eligible residents of West Philadelphia, patients are contacted by Community Support Program Representative and offered free Lyft transportation to and from appointment. If patient has other questions about their upcoming appointment (location, time, etc.), Patient Navigator assists in answering questions. This group opted into the CSP.
|
West Philadelphia Non CSP Participants
n=165 Participants
For eligible residents of West Philadelphia, patients are contacted by Community Support Program Representative and offered free Lyft transportation to and from appointment. If patient has other questions about their upcoming appointment (location, time, etc.), Patient Navigator assists in answering questions. This group did not opt into the CSP.
|
Southwest Philadelphia Residents
n=51 Participants
For patients outside West Philadelphia, no contact is made and no free transportation is provided. Research coordinator logs their appointment attendance after the appointment date in question.
|
Total
n=242 Participants
Total of all reporting groups
|
|---|---|---|---|---|
|
Age, Customized
Age 18-89
|
26 participants
n=5 Participants
|
165 participants
n=7 Participants
|
51 participants
n=5 Participants
|
242 participants
n=4 Participants
|
|
Sex: Female, Male
Female
|
18 Participants
n=5 Participants
|
98 Participants
n=7 Participants
|
28 Participants
n=5 Participants
|
144 Participants
n=4 Participants
|
|
Sex: Female, Male
Male
|
8 Participants
n=5 Participants
|
67 Participants
n=7 Participants
|
23 Participants
n=5 Participants
|
98 Participants
n=4 Participants
|
|
Ethnicity (NIH/OMB)
Hispanic or Latino
|
0 Participants
n=5 Participants
|
1 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
1 Participants
n=4 Participants
|
|
Ethnicity (NIH/OMB)
Not Hispanic or Latino
|
26 Participants
n=5 Participants
|
162 Participants
n=7 Participants
|
51 Participants
n=5 Participants
|
239 Participants
n=4 Participants
|
|
Ethnicity (NIH/OMB)
Unknown or Not Reported
|
0 Participants
n=5 Participants
|
2 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
2 Participants
n=4 Participants
|
|
Race (NIH/OMB)
American Indian or Alaska Native
|
0 Participants
n=5 Participants
|
2 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
2 Participants
n=4 Participants
|
|
Race (NIH/OMB)
Asian
|
0 Participants
n=5 Participants
|
1 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
1 Participants
n=4 Participants
|
|
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
0 Participants
n=4 Participants
|
|
Race (NIH/OMB)
Black or African American
|
26 Participants
n=5 Participants
|
149 Participants
n=7 Participants
|
48 Participants
n=5 Participants
|
223 Participants
n=4 Participants
|
|
Race (NIH/OMB)
White
|
0 Participants
n=5 Participants
|
11 Participants
n=7 Participants
|
3 Participants
n=5 Participants
|
14 Participants
n=4 Participants
|
|
Race (NIH/OMB)
More than one race
|
0 Participants
n=5 Participants
|
1 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
1 Participants
n=4 Participants
|
|
Race (NIH/OMB)
Unknown or Not Reported
|
0 Participants
n=5 Participants
|
1 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
1 Participants
n=4 Participants
|
|
Region of Enrollment
United States
|
26 participants
n=5 Participants
|
165 participants
n=7 Participants
|
51 participants
n=5 Participants
|
242 participants
n=4 Participants
|
|
Scheduled Lung Cancer Screening
|
26 participants
n=5 Participants
|
165 participants
n=7 Participants
|
51 participants
n=5 Participants
|
242 participants
n=4 Participants
|
PRIMARY outcome
Timeframe: 12 monthsThe Primary Outcome measures the rate of appointment attendance across three groups: West Philadelphia CSP Participants (eligible West Philadelphia residents who opted into the CSP), West Philadelphia Non CSP Participants (eligible West Philadelphia residents who did not opt into the CSP), and Southwest Philadelphia Residents (patients who did not receive an option to participate in the CSP).
Outcome measures
| Measure |
West Philadelphia CSP Participants
n=26 Participants
West Philadelphia CSP Participants For eligible residents of West Philadelphia, patients are contacted by Community Support Program Representative and offered free Lyft transportation to and from appointment. If patient has other questions about their upcoming appointment (location, time, etc.), Patient Navigator assists in answering questions. This group opted into the CSP.
|
West Philadelphia Non CSP Participants
n=165 Participants
For eligible residents of West Philadelphia, patients are contacted by Community Support Program Representative and offered free Lyft transportation to and from appointment. If patient has other questions about their upcoming appointment (location, time, etc.), Patient Navigator assists in answering questions. This group did not opt into the CSP.
|
Southwest Philadelphia Residents
n=51 Participants
For patients outside West Philadelphia, no contact is made and no free transportation is provided. Research coordinator logs their appointment attendance after the appointment date in question.
|
|---|---|---|---|
|
Percentage of Scheduled Lung Cancer Screening Appointments Attended by Participants
|
88 % of lcs appointment attendance
|
68 % of lcs appointment attendance
|
64 % of lcs appointment attendance
|
SECONDARY outcome
Timeframe: 12 monthsThe Secondary outcome is a measurement of the percentage of eligible participants (West Philadelphia residents) who chose to opt into the CSP (as opposed to eligible participants who did not).
Outcome measures
| Measure |
West Philadelphia CSP Participants
n=191 Participants
West Philadelphia CSP Participants For eligible residents of West Philadelphia, patients are contacted by Community Support Program Representative and offered free Lyft transportation to and from appointment. If patient has other questions about their upcoming appointment (location, time, etc.), Patient Navigator assists in answering questions. This group opted into the CSP.
|
West Philadelphia Non CSP Participants
For eligible residents of West Philadelphia, patients are contacted by Community Support Program Representative and offered free Lyft transportation to and from appointment. If patient has other questions about their upcoming appointment (location, time, etc.), Patient Navigator assists in answering questions. This group did not opt into the CSP.
|
Southwest Philadelphia Residents
For patients outside West Philadelphia, no contact is made and no free transportation is provided. Research coordinator logs their appointment attendance after the appointment date in question.
|
|---|---|---|---|
|
Percentage of CSP Enrollment
|
14 percentage of participants
|
—
|
—
|
Adverse Events
West Philadelphia Residents
Non West Philadelphia Residents
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place